Correlation Between Genovis AB and IRLAB Therapeutics
Specify exactly 2 symbols:
By analyzing existing cross correlation between Genovis AB and IRLAB Therapeutics AB, you can compare the effects of market volatilities on Genovis AB and IRLAB Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovis AB with a short position of IRLAB Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovis AB and IRLAB Therapeutics.
Diversification Opportunities for Genovis AB and IRLAB Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Genovis and IRLAB is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Genovis AB and IRLAB Therapeutics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IRLAB Therapeutics and Genovis AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovis AB are associated (or correlated) with IRLAB Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IRLAB Therapeutics has no effect on the direction of Genovis AB i.e., Genovis AB and IRLAB Therapeutics go up and down completely randomly.
Pair Corralation between Genovis AB and IRLAB Therapeutics
Assuming the 90 days trading horizon Genovis AB is expected to generate 0.48 times more return on investment than IRLAB Therapeutics. However, Genovis AB is 2.07 times less risky than IRLAB Therapeutics. It trades about 0.2 of its potential returns per unit of risk. IRLAB Therapeutics AB is currently generating about -0.16 per unit of risk. If you would invest 2,010 in Genovis AB on April 21, 2025 and sell it today you would earn a total of 775.00 from holding Genovis AB or generate 38.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Genovis AB vs. IRLAB Therapeutics AB
Performance |
Timeline |
Genovis AB |
IRLAB Therapeutics |
Genovis AB and IRLAB Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Genovis AB and IRLAB Therapeutics
The main advantage of trading using opposite Genovis AB and IRLAB Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovis AB position performs unexpectedly, IRLAB Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IRLAB Therapeutics will offset losses from the drop in IRLAB Therapeutics' long position.Genovis AB vs. Ascendis Pharma AS | Genovis AB vs. Alligator Bioscience AB | Genovis AB vs. Bavarian Nordic | Genovis AB vs. Biotage AB |
IRLAB Therapeutics vs. Sprint Bioscience AB | IRLAB Therapeutics vs. Intervacc AB | IRLAB Therapeutics vs. Fluicell AB | IRLAB Therapeutics vs. Galecto |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |